reference/16033638

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16033638

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	855
issn	1365-2141 0007-1048
issueIdentifier	6
pageRange	848-855
publicationName	British Journal of Haematology
startingPage	848
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b9e91fe3650b699f125351fcf739dfa6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2072a2fb17378403397ab0ff130ff5b3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3e44adb29a5a376efd2772020e86388e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2a78a652a4c0a563f591c5f602883f84 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_372ae9cf51e81a7571eb1ff3c4d13149 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_104f0f5963fbf87dffe9bc0379f81019 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4317c385dd48fc06a5ae571e37fb09c9
bibliographicCitation	Lapalombella R, Gowda A, Joshi T, Mehter N, Cheney C, Lehman A, Chen C, Johnson AJ, Caligiuri MA, Tridandapani S, Muthusamy N, Byrd JC. The humanized CD40 antibody SGN‐40 demonstrates pre‐clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. Br J Haematol. 2009 Feb 19;144(6):848–55. doi: 10.1111/j.1365-2141.2008.07548.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b28057b89739a0094fa9e0a8a722f9e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab73fd1eb7a2bc5525d662f2cc2ae7a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28029bbc5397182f2851189e1132809c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38e3a7336fd99074423c1ebc8513978a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab7408008e1a24b67eefd8c8ff4902d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9d2d006108dcc54b4a398ee0fa510ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c58e0cd67865d3ff35c01b8ec82adfe7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2893033b927d2dab3e0e145dad6003d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc2398a23abdd479ff1731895610199b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22ff6952bbc99682220f289bf9e8b863 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c73f75c02e6e8d729a89c58711aa867d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68fb96f4028d3ba91ff9bf5fa8b91cc0
date	2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2776067 https://doi.org/10.1111/j.1365-2141.2008.07548.x https://pubmed.ncbi.nlm.nih.gov/19183192
isPartOf	https://portal.issn.org/resource/ISSN/0007-1048 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1822 https://portal.issn.org/resource/ISSN/1365-2141
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The humanized CD40 antibody SGN‐40 demonstrates pre‐clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia
discusses	http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0028391 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0479831
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D015451Q000188 http://id.nlm.nih.gov/mesh/D013792Q000031 http://id.nlm.nih.gov/mesh/D019013Q000276 http://id.nlm.nih.gov/mesh/D000911Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077269 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D007694Q000276 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001402Q000276 http://id.nlm.nih.gov/mesh/D003601 http://id.nlm.nih.gov/mesh/D013792Q000627 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D015451Q000276
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a92f8ed870be1881ab70c89e8f2b1e38 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249267819

Total number of triples: 69.